Apollon Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Sell |
3,348
-146
| -4% | -$76.7K | 0.03% | 386 |
|
|
2025
Q1 | $2.22M | Buy |
3,494
+1,772
| +103% | +$1.12M | 0.05% | 313 |
|
|
2024
Q4 | $1.23M | Buy |
1,722
+130
| +8% | +$92.6K | 0.03% | 448 |
|
|
2024
Q3 | $1.67M | Sell |
1,592
-83
| -5% | -$87.3K | 0.05% | 348 |
|
|
2024
Q2 | $1.76M | Sell |
1,675
-30
| -2% | -$31.5K | 0.05% | 323 |
|
|
2024
Q1 | $1.64M | Buy |
1,705
+418
| +32% | +$402K | 0.05% | 336 |
|
|
2023
Q4 | $1.13M | Buy |
1,287
+314
| +32% | +$276K | 0.04% | 411 |
|
|
2023
Q3 | $801K | Buy |
973
+62
| +7% | +$51K | 0.04% | 422 |
|
|
2023
Q2 | $655K | Buy |
911
+151
| +20% | +$109K | 0.03% | 525 |
|
|
2023
Q1 | $624K | Sell |
760
-40
| -5% | -$32.9K | 0.04% | 465 |
|
|
2022
Q4 | $577K | Sell |
800
-562
| -41% | -$405K | 0.04% | 463 |
|
|
2022
Q3 | $938K | Buy |
1,362
+110
| +9% | +$75.8K | 0.08% | 268 |
|
|
2022
Q2 | $740K | Sell |
1,252
-68
| -5% | -$40.2K | 0.06% | 333 |
|
|
2022
Q1 | $922K | Sell |
1,320
-30
| -2% | -$21K | 0.07% | 307 |
|
|
2021
Q4 | $853K | Buy |
1,350
+130
| +11% | +$82.1K | 0.06% | 323 |
|
|
2021
Q3 | $738K | Sell |
1,220
-251
| -17% | -$152K | 0.1% | 190 |
|
|
2021
Q2 | $822K | Sell |
1,471
-318
| -18% | -$178K | 0.15% | 134 |
|
|
2021
Q1 | $846K | Buy |
+1,789
| New | +$846K | 0.16% | 122 |
|
|
2020
Q3 | – | Sell |
-16
| Closed | -$10K | – | 568 |
|
|
2020
Q2 | $10K | Buy |
+16
| New | +$10K | 0.01% | 499 |
|